Thursday, Dec 26, 2024 · SEC filings
What the smart money revealed on Dec 26
463 insider filings came in. We hid 69 planned (10b5-1) sellers and 235 people whose filings were routine, like grants and tax withholding.
Anebulo Pharmaceuticals (ANEB) Director Aron English bought $10M
10.1M shares on the open market. Not a grant or an option exercise.
TechTarget (TTGT) Director Michael Griffey bought $3.54M
148,248 shares on the open market. Not a grant or an option exercise.
Progyny (PGNY) CEO Peter Anevski bought $3.03M
209,500 shares on the open market. Not a grant or an option exercise.
Progyny (PGNY) Executive Chairman David Schlanger bought $2.2M
150,000 shares on the open market. Not a grant or an option exercise.
Altice USA (OPTU) Director Patrick Drahi sold $19.7M
Not marked as a planned 10b5-1 sale. Sold 12% of the shares they held directly. Still holds 5.85M shares.
Roivant Sciences (ROIV) Pres&Chief Investment Officer Mayukh Sukhatme sold $10.6M
Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 18.84M shares directly.
Avid Bioservices (CDMO) President and CEO Nicholas Green sold $2.79M
Not marked as a planned 10b5-1 sale. Sold every share held directly.
Show 39 more real buys
Show 81 more real sales
13F season
Holdings as of Sep 30, 2024 were due Nov 14
58 funds have filed. 54 filed for the quarter before.
Biggest real insider buys, Dec 20–26
Open-market buys by officers and directors, filed in the 7 days up to Dec 26.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.